89bio, Inc.
ETNB
$9.04
$0.273.08%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -56.44% | 39.78% | 20.61% | -210.76% | 7.18% |
| Total Depreciation and Amortization | -20.00% | 11.11% | 12.50% | -33.33% | 33.33% |
| Total Amortization of Deferred Charges | -30.11% | 39.57% | 86.29% | 4.17% | 3.70% |
| Total Other Non-Cash Items | -7.85% | 57.63% | -23.34% | 51.46% | 22.25% |
| Change in Net Operating Assets | 195.46% | 10.31% | -739.17% | 94.94% | -272.13% |
| Cash from Operations | -39.99% | 41.00% | 16.36% | -137.65% | -53.99% |
| Capital Expenditure | 100.00% | -380.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,273.82% | -139.12% | 329.64% | -131.02% | 134.86% |
| Cash from Investing | -1,261.19% | -139.51% | 329.47% | -131.02% | 134.86% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -92.11% | 97.67% | 451.85% | -11.18% | 21.30% |
| Repurchase of Common Stock | 44.85% | -5,622.22% | 98.01% | -2,217.95% | 97.69% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.00% | 154.15% |
| Cash from Financing | -92.29% | 97.14% | 310.97% | 18.71% | 32.95% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -198.41% | 446.44% | 128.68% | -2,155.97% | 94.57% |